Ocean Biomedical, Inc.
OCEA
$0.0061
-$0.0006-8.96%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.14M | 3.77M | 1.38M | 2.96M | 5.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.16M | 3.80M | 1.39M | 3.27M | 5.42M |
| Operating Income | -4.16M | -3.80M | -1.39M | -3.27M | -5.42M |
| Income Before Tax | -30.72M | -9.48M | -26.62M | -35.18M | -29.38M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -30.72 | -9.48 | -26.62 | -35.18 | -29.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -30.72M | -9.48M | -26.62M | -35.18M | -29.38M |
| EBIT | -4.16M | -3.80M | -1.39M | -3.27M | -5.42M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.91 | -0.34 | -0.97 | -1.30 | -1.11 |
| Normalized Basic EPS | -0.57 | -0.21 | -0.61 | -0.81 | -0.66 |
| EPS Diluted | -0.91 | -0.34 | -0.97 | -1.30 | -1.11 |
| Normalized Diluted EPS | -0.57 | -0.21 | -0.61 | -0.81 | -0.66 |
| Average Basic Shares Outstanding | 173.67M | 109.99M | 109.55M | 108.67M | 107.65M |
| Average Diluted Shares Outstanding | 173.67M | 109.99M | 109.55M | 108.67M | 107.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |